2012-08-13T13:26:59-05:00 2012-03-31 910189318 MOSS ADAMS LLP 9665 GRANITE RIDGE DRIVE SUITE 600 SAN DIEGO CA 92123 990 2011-04-01 954002032 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH ALFR 6617026700 25134 RYE CANYON LOOP NO 200 SANTA CLARITA CA 91355 DAVID HANKIN 6617026700 2012-08-10 1 PATRICIA J MAYER P00188643 8586271400 2011 2016-02-24 21:20:13Z DAVID HANKIN 25134 RYE CANYON LOOP NO 200 SANTA CLARITA CA 91355 62738507 0 X WWW.AEMF.ORG X 1985 CA CONDUCT MEDICAL AND SCIENTIFIC RESEARCH 5 4 126 12 0 0 990071 1281308 0 0 8294980 6288396 3081838 3584399 12366889 11154103 36000 14120 0 0 13055840 13735353 0 0 366968 8903530 10950267 21995370 24699740 -9628481 -13545637 149147272 127153690 15477095 14940475 133670177 112213215 X THE ALFRED MANN FOUNDATION IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO BRINGING ADVANCED MEDICAL TECHNOLOGIES TO THE PUBLIC TO PROVIDE SIGNIFICANT IMPROVEMENTS TO THE HEALTH, SECURITY AND QUALITY OF LIFE FOR PEOPLE SUFFERING FROM DEBILITATING MEDICAL CONDITIONS. 0 0 5450538 14120 IMES: THE IMES PROJECT IS A CONSORTIUM PROJECT WITH THE FOLLOWING PARTNERS: NORTHWESTERN UNIVERSITY, THE ILLINOIS INSTITUTE OF TECHNOLOGY, AND SIGENICS (A CLOSELY HELD ENGINEERING COMPANY). THE INITIAL FUNDING FOR THE IMES PROGRAM IS COMING FROM THE NATIONAL INSTITUTES FOR BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) AND THE NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD) AS WELL AS THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA). THE IMPLANTABLE MYOELECTRIC SENSOR (IMES) SYSTEM IMPLANTED IN THE RESIDUAL LIMB OF A GROSS LIMB AMPUTEE WOULD TRANSMIT NERVE SIGNALS TO THE WEARABLE PROSTHESIS TO PERMIT CONTROL OF THE PROSTHESIS IN A MORE NATURAL MANNER. INITIALLY, AMF WAS A SUBCONTRACTOR TO PROVIDE ENGINEERING AND MANUFACTURING SERVICES TO PACKAGE AN IMPLANT SUITABLE FOR FURTHER STUDY. IN THE LAST FEW YEARS, AMF HAS ASSUMED A MORE CENTRAL ROLE, PERFORMING KEY ENGINEERING TASK AND PREPARING FOR A CLINICAL TRIAL.STATUS: AMF APPLIED MAJOR FOCUSED EFFORTS ON THE IMES PROGRAM RESULTING IN THE COMPLETION OF FULL QUALIFICATION OF THE DEVICE. ALL OF THE REQUIRED EXTERNAL HARDWARE WAS DEVELOPED AND THE IMPLANT CHIP WAS REDESIGNED TO IMPROVE MANUFACTURABILITY. A CLINICAL TRIAL PROTOCOL WAS DEVELOPED AND IS READY FOR SUBMISSION TO THE FDA AND THE PROPOSED CLINICAL SITE (WALTER REED ARMY MEDICAL CENTER). 4765558 IMPLANTABLE PAIN PUMP: IN DECEMBER 2009, AMF PURCHASED THE ASSETS OF A COMPANY CALLED INFUSION SYSTEMS. THE ASSETS INCLUDED, AMONG OTHER THINGS, THE INTELLECTUAL PROPERTY AND HARD ASSETS/EQUIPMENT NECESSARY TO BUILD AN IMPLANTABLE INFUSION PUMP THAT CAN BE USED TO PUMP VARIOUS PHARMACEUTICAL PRODUCTS INTO THE HUMAN BODY SAFELY AND ACCURATELY. THE INITIAL APPLICATION IS FOR PAIN MANAGEMENT USING MORPHINE. STATUS: THE FOUNDATION SUBMITTED AND THE FDA APPROVED AN IDE APPLICATION TO START A HUMAN CLINICAL TRIAL FOR PAIN MANAGEMENT USING INFUMORPH. FOURTEEN PATIENTS WERE IMPLANTED WITH PUMPS AT FIVE SEPARATE CENTERS, THE CAROLINAS PAIN INSTITUTE, UC SAN DIEGO, SPECTRUM CARE PAIN TREATMENT CENTER, MILLENNIUM PAIN CENTER, CENTER FOR PAIN AND SUPPORTING CARE. IN PARALLEL, SYSTEM COMPONENTS AND ACCESSORY INVENTORY WAS BUILT TO SUPPORT THE 75 PATIENT HUMAN TRIAL. ON AN ONGOING BASIS, VARIOUS ENGINEERING PROJECTS WERE IN DEVELOPMENT FOCUSING ON: A NEW TABLET PROGRAMING PLATFORM AND TWO NEW PUMP DESIGNS, ONE WITH A SMALL DRUG RESERVOIR AND ONE WITH A LARGER RESERVOIR. 4639317 3975000 FEBPM: THE FUNCTION ELECTRICAL STIMULATION BATTERY POWERED MICROSTIMULATOR (FEBPM) PROGRAM (FORMERLY THE BATTERY POWERED MICROSTIMULATOR (BPM) PROGRAM) IS THE DEVELOPMENT OF THE NEXT-GENERATION MICROSTIMULATOR SYSTEM. IT IS DESIGNED FOR A WIDE RANGE OF MEDICAL APPLICATIONS INCLUDING LOCALIZED INDIVIDUAL MUSCLE CONTROL AND ORCHESTRATED MUSCLE GROUP CONTROL. THE PRESENT MICROSTIMULATOR (RFM - SEE BELOW) IS POWERED AND CONTROLLED THROUGH AN EXTERNAL RF FIELD AND ONLY A FEW MICROSTIMULATORS CAN BE CONTROLLED AT ONCE USING A CONTROL ALGORITHM INSTALLED ON A PC AND UTILIZING LIMITED ACTIVITY SEQUENCES. BY CONTRAST, THE FEBPM IMPLANT HAS ITS OWN POWER SUPPLY WHICH CAN BE RECHARGED AS NEEDED AND THEN CAN OPERATE FOR PERIODS OF TIME. NUMEROUS FEBPM'S CAN BE COMMUNICATED WITH AND CONTROLLED USING ONE EXTERNAL CONTROLLER. FUTURE VERSIONS OF THE FEBPM SYSTEM MAY ALSO CONTAIN SENSORS CAPABLE OF COMMUNICATING BACK TO THE CONTROLLER TO DELIVER VARIOUS TYPES OF INFORMATION USED FOR SYSTEM OPERATION.STATUS: A MAJOR MILESTONE WAS REACHED DURING 2011 WHEN THE FCC ISSUED AN ORDER ENABLING THE FOUNDATION TO SHARE A SMALL RANGE OF RADIO FREQUENCY IN HARMONY WITH THE EXISTING USERS. THIS APPROVAL IN CONJUNCTION WITH EFFECTIVELY SECURING A COUPLE OF KEY COMPONENT SUPPLIERS HAS ALLOWED THE PROGRAM TO ONCE AGAIN MOVE FORWARD. THE MAJOR CHALLENGES REMAINING FOCUS ON THE DEVICES FINAL QUALIFICATION TESTING AND DETERMINATION OF THE INITIAL CLINICAL TRIAL APPLICATION. 6260811 0 NEW PROJECTS: A) ICPM: INITIAL DEVELOPMENT WORK BEGAN ON A NEW TECHNOLOGY ALLOWING THE MONITORING OF INTERCRANIAL PRESSURE. THE GOAL OF THIS PROJECT IS TO COUPLE A PRESSURE SENSOR TO THE INTRA-VENTRICULAR CATHETER OF A HYDROCEPHALUS SHUNT IN ORDER TO MONITOR INTRACRANIAL CSF PRESSURE IN REAL TIME, TO MONITOR THE ADEQUACY AND EFFECTIVENESS OF INDIVIDUAL PATIENTS' SHUNT OPERATION, AND TO PROTECT THE HEALTH OF SHUNT PATIENTS. THE MAJOR AREA OF FOCUS DURING THE INITIAL FEASIBILITY ANALYSIS IS DRIFT THAT RESULTS FROM VARIOUS FORCES PLACED ON THE SENSOR. OVER TIME THE BUILT IN FORCES CAUSE THE OUTPUT TO DRIFT AND RESULT IN INACCURATE READINGS.STATUS: A POTENTIAL LICENSEE HAS BEEN LOCATED, AND AMF HAS FILED JOINTLY WITH THIS COMPANY FOR GRANT FUNDING TO ADVANCE DEVELOPMENT OF THIS PROGRAM. IF THE GRANT IS RECEIVED AND COMPLETED SUCCESSFULLY, IT IS LIKELY THAT THE PARTNER COMPANY WILL EITHER OPTION OR LICENSE THE ICPM PROGRAM TECHNOLOGY. IF THIS DOES NOT OCCUR, AMF DOES NOT INTEND TO CONTINUE FUNDING FOR THIS PROGRAM. B) AP: THE ARTIFICIAL PANCREAS DEVELOPMENT PATH CONSISTS OF SEVERAL STEPS CULMINATING IN A FULLY IMPLANTABLE, CLOSED-LOOP, AUTONOMOUS ARTIFICIAL ENDOCRINE PANCREAS. SUCH A SYSTEM WILL MAINTAIN BLOOD GLUCOSE LEVELS IN DIABETICS TO NORMAL RANGE WITHOUT RISK OF HYPOGLYCEMIA (LOW BLOOD GLUCOSE). FOUR MAJOR COMPONENTS CONSTITUTE THE AP SYSTEM: AN IMPLANTABLE PUMP DELIVERING INSULIN TO THE INTRAPERITONEAL SPACE, INSULIN WHICH IS STABLE AT BODY TEMPERATURE, AN IMPLANTABLE GLUCOSE SENSOR, AND A CONTROL ALGORITHM.STATUS: AFTER SIGNIFICANT DUE DILIGENCE ON VARIOUS SENSOR TECHNOLOGIES AND CONTROL ALGORITHMS, EFFORTS TO OBTAIN EXTERNAL FUNDING ON TERMS SATISFACTORY TO AMF WERE ULTIMATELY NOT SUCCESSFUL. A DECISION WAS MADE TO TERMINATE ACTIVE DEVELOPMENT EFFORTS RELATING TO THIS PROGRAM, BUT FOR THE LIMITED EFFORTS OF ONE EMPLOYEE WHO IS ATTEMPTING TO GATHER FINANCIAL AND TECHNOLOGICAL SUPPORT FOR A DEVELOPMENT EFFORT THAT LIKELY WOULD BE CARRIED ON IN A NEWLY-LAUNCHED STARTUP ENTITY THAT WOULD BE FUNDED BY THIRD PARTIES AND WHICH WOULD LICENSE AP-RELATED INTELLECTUAL PROPERTY FROM AMF. RFM: THE RADIO FREQUENCY MICROSTIMULATOR (RFM) IS A SYSTEM OF DEVICES INTENDED TO STIMULATE NERVES TO CONTROL MUSCLE MOVEMENT IN PATIENTS WHO HAVE EXPERIENCED A DEBILITATING MUSCLE/NERVE INJURY OR DISEASE. THE SYSTEM CONSISTS OF IMPLANTED MICROSTIMULATORS, SURGICAL TOOLS USED TO IMPLANT THE MICROSTIMULATORS, EXTERNAL COMPONENTS USED TO POWER THE IMPLANTED MICROSTIMULATORS (A CONTROL UNIT AND RF COIL), AND A LAPTOP WITH CUSTOM SOFTWARE USED TO PROGRAM THE MICROSTIMULATORS. STATUS: IN CONNECTION WITH THE PREVIOUS FEASIBILITY STUDY, ENGINEERING WORK WAS PERFORMED TO ENHANCE SYSTEM FEATURES AND FUNCTIONALITY REQUIRED TO MEET USER NEEDS. ENGINEERING AND REGULATORY ACTIVATES HAVE BEEN CARRIED OUT TO SUPPORT A IDE SUBMISSIONS FOR A CLINICAL STUDY FOR ARM REHAB DUE TO TRAUMATIC BRAIN INJURY. WE HAVE IMPLANTED THE FIRST PATIENT IN THE TRIAL AT THE TAMPA VA. 6260811 21116224 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 1 0 1 0 0 0 1 0 0 0 1 1 0 0 0 0 1 0 0 0 0 1 72 0 1 126 1 0 0 0 0 0 1 1 0 0 0 0 X 5 4 1 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X FARAH BOROOMAND 6617026731 25134 RYE CANYON LOOP SUITE 200 SANTA CLARITA CA 91355 ALFRED MANN 3.00 X 0 0 0 BRIAN MANN 2.00 X 0 0 0 KENT KRESA 2.00 X 0 0 0 ROBERT GREENBERG 2.00 X X 0 0 0 RICHARD WAUGH 2.00 X 0 0 0 MARI DANIHEL 2.00 X 0 0 0 DAVID HANKIN 55.00 X 372712 0 35018 FARAH BOROOMAND 50.00 X 216443 0 8147 MARK CHAMBERLAIN 52.00 X 289948 0 29081 DAN MERRILL 43.00 X 196227 0 20936 GUANGQIANG JIANG 45.00 X 209968 0 32885 JOHN PETROVICH 53.00 X 232704 0 31369 STEPHEN HESSELL 42.00 X 220845 0 29797 MICHAEL PERRIN 43.00 X 158368 0 19636 PETER LORD 40.00 X 172528 0 20313 EUSEBIU MATEI 40.00 X 208981 0 21368 JAMES WOLFE 40.00 X 164128 0 31212 HOWARD STOVER 40.00 X 172768 0 11798 GLEN GRIFFITH 40.00 X 176980 0 28222 2792600 0 319782 45 0 1 0 KAYE SCHOLER LLP 1999 AVENUE OF THE STARS STE 1600 LOS ANGELES CA 90067 LEGAL SERVICES 894096 PODESTA GROUP INC 1001 G STREET NW STE 900 EAST WASHINGTON DC 20001 PROGRAM SERVICES 300000 HENRICKS SLAVIN & HOLMES LLP 840 APOLLO STREET 200 EL SEGUNDO CA 90245 LEGAL SERVICES 168465 WILKINSON BARKER KNAUER LLP 2300 N STREET NW 700 WASHINGTON DC 20037 LEGAL SERVICES 166728 TOM XIAOHAI HE 19907 VIA OTT SANTA CLARITA CA 91321 CONSULTING SERVICES 152400 6 887339 26659 367310 1281308 4481136 4481136 3975000 3975000 52830980 12583 51008365 27938 1822615 -15355 1807260 1807260 157500 887339 548101 -390601 -390601 11154103 3975000 0 5897795 14120 14120 2185698 1801271 384427 9623880 8477081 940713 206086 149170 133673 14060 1437 910993 782385 105867 22741 865612 757303 92921 15388 1975303 1783143 192160 85468 85468 1807392 877389 922428 7575 2885006 2710875 128170 45961 198918 150950 44912 3056 1265592 1135836 97317 32439 304166 220379 68108 15679 76805 46991 23089 6725 1158966 1073968 82992 2006 114094 93062 15774 5258 RESEARCH K-1 ALLOCATION 935966 935966 EDUCATION & MORALE 89561 76567 10781 2213 MISCELLANEOUS 53030 45265 7361 404 24699740 21116224 3216548 366968 401231 368867 1367375 1362386 614719 357134 10078562 10000000 580006 155095 10721483 8344702 3298862 2376781 122636134 107105926 7221573 2334229 1979379 1915888 969431 1177384 149147272 127153690 2278523 1856256 12921364 13084219 277208 0 15477095 14940475 X 133670177 112213215 133670177 112213215 149147272 127153690 X -13545637 -7911325 X 0 1 1 X 0 X COUNTY USC MEDICAL CENTER LOS ANGELES CA SHEPHERD CENTER ATLANTA GA SHRINER'S CHILDREN'S HOSPITAL PHILADELPHIA PA JAMES A HALEY VA MEDICAL CENTER TAMPA FL WALTER REED ARMY MEDICAL WASHINGTON DC THE CENTER FOR CLINICAL RESEARCH WINSTONSALEM NC UCSD CENTER FOR PAIN MEDICINE SAN DIEGO CA NEUROVATIONS NAPA CA MILLENNIUM PAIN CENTER BLOOMINGTON IL THE CENTER FOR PAIN AND SUPPORTIVE CARE PHOENIX AZ RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1481078 268105 1212973 5160121 4283251 876870 4080284 3793346 286938 2376781 11154103 24699740 -13545637 -3959947 -3951378 -7911325 -21456962 7194156 -3959947 -3959947 11154103 0 11154103 28651118 4887344 4887344 23763774 935966 935966 24699740 PART XI, LINE 8 - OTHER ADJUSTMENTS: IMPAIRMENT ON OTHER INVESTMENT -4,887,344. K-1 RESEARCH ACTIVITY ALLOCATION 935,966. TOTAL TO SCHEDULE D, PART XI, LINE 8: -3,951,378. PART XIII, LINE 2D - OTHER ADJUSTMENTS: IMPAIRMENT ON OTHER INVESTMENT 4,887,344. PART XIII, LINE 4B - OTHER ADJUSTMENTS: K-1 RESEARCH ACTIVITY ALLOCATION 935,966. PART X, LINE 2: THE FOUNDATION, UNDER THE PROVISIONS OF ASC 740, INCOME TAXES, HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL AS OF MARCH 31, 2012. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 6501313 0 0 0 0 0 0 6501313 0 6501313 1 0 1 1 1 0 GALA 1044839 887339 157500 548101 1044839 887339 157500 548101 548101 -390601 1 X PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: AMOUNTS PROVIDED ARE TO PUBLIC CHARITIES, ACCOUNTING DEPARTMENT MAINTAINS BACKUP DETAILS. X X X 0 0 0 0 0 0 0 1 0 DAVID HANKIN 280712 0 80000 0 12000 0 4851 0 30167 0 407730 0 0 0 FARAH BOROOMAND 181443 0 35000 0 0 0 3682 0 4465 0 224590 0 0 0 MARK CHAMBERLAIN 239948 0 50000 0 0 0 4802 0 24279 0 319029 0 0 0 DAN MERRILL 176227 0 20000 0 0 0 3577 0 17359 0 217163 0 0 0 GUANGQIANG JIANG 179968 0 30000 0 0 0 3762 0 29123 0 242853 0 0 0 JOHN PETROVICH 207704 0 25000 0 0 0 4249 0 27120 0 264073 0 0 0 STEPHEN HESSELL 205845 0 15000 0 0 0 4148 0 25649 0 250642 0 0 0 MICHAEL PERRIN 133368 0 25000 0 0 0 858 0 18778 0 178004 0 0 0 PETER LORD 168528 0 4000 0 0 0 2969 0 17344 0 192841 0 0 0 EUSEBIU MATEI 198981 0 10000 0 0 0 3991 0 17377 0 230349 0 0 0 JAMES WOLFE 164128 0 0 0 0 0 3407 0 27805 0 195340 0 0 0 HOWARD STOVER 152768 0 20000 0 0 0 3021 0 8777 0 184566 0 0 0 GLEN GRIFFITH 176980 0 0 0 0 0 3575 0 24647 0 205202 0 0 0 PART I, LINE 7 BONUS PAYMENTS WERE MADE, BUT ARE BASED ON ACHIEVEMENTS, GOALS, AND ARE APPROVED BY BOARD OF DIRECTORS. BIONESS INC - INDIRECT 35 OWNERSHIP BY ALFRED E MANN MEMBER BRIDGE LOAN X 10000000 10000000 0 1 1 ROUNDTRIP LLC - INDIRECT 35 OWNERSHIP BY ALFRED E MANN MEMBER LOAN FOR INVESTMENT OPERATIONS X 525775 0 0 1 1 10000000 MANN BIOMEDICAL PARK LLC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 715164 THE FOUNDATION IS PARTY TO TWO LEASES WITH MANN BIOMEDICAL PARK, LLC FOR THE FOLLOWING FACILITIES: 1) 25133 RYE CANYON LOOP, SANTA CLARITA FOR $1,649 PER MONTH, AND 2) 25134 RYE CANYON LOOP, SANTA CLARITA FOR $57,948 PER MONTH. 0 MANNCO LLC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 497160 THE FOUNDATION IS PARTY TO ONE LEASE WITH MANNCO, LLC FOR THE FACILITY AT 28575 LIVINGSTON AVE., VALENCIA FOR $41,430 PER MONTH 0 BIONESS INC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 935445 INTEREST PAID TO ORGANIZATION ON BRIDGE LOAN 0 PERQFLO LLC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 63563 PERQFLO, LLC IS SUBLESSOR FOR $9,080 PER MONTH STARTING ON SEPTEMBER 1, 2011 0 X VALUABLE ITEM 6 0 NONE 0 0 0 NON REPORTING OF REVENUE: PART I, LINE 33: THE DONATED ITEMS WERE NOT RECORDED WHEN THEY WERE RECEIVED, BUT THE PROCEEDS FROM SELLING THEM WERE RECORDED AS REVENUE. THESE ITEMS WERE DONATED SHORTLY BEFORE THE ANNUAL FUNDRAISING EVENT. FORM 990, PART VI, SECTION A, LINE 2 BRIAN MANN AND ALFRED MANN, FAMILY RELATIONSHIP KEN KRESA AND ALFRED MANN, BUSINESS RELATIONSHIP ROB GREENBERG AND ALFRED MANN, BUSINESS RELATIONSHIP FORM 990, PART VI, SECTION A, LINE 6 THE FOUNDATION HAS A SINGLE MEMBER WHO MAY APPOINT OR REMOVE MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A THE FOUNDATION HAS A SINGLE MEMBER WHO MAY APPOINT OR REMOVE MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 A DRAFT OF FORM 990 WAS PRESENTED BY MANAGEMENT TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS, AND A FULL COPY OF THE FORM WAS PROVIDED TO ALL VOTING MEMBERS PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURES ARE UPDATED ANNUALLY AND POTENTIAL CONFLICTS ARE REVIEWED PRIOR TO PARTICIPATING IN TRANSACTIONS.IF A CONFLICT EXISTS, THE PERSON WITH A CONFLICT DOES NOT VOTE. THERE HAVE BEEN NO INCIDENCES THIS REPORTING YEAR. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE COMPENSATION OF THE CEO AND CFO. THEY ALSO REVIEW AND APPROVE THE OVERALL ANNUAL ADJUSTMENTS TO COMPENSATION OF OTHER EMPLOYEES. SPECIFIC ADJUSTMENTS FOR OTHER EMPLOYEES ARE HANDLED BY THE CEO AND HEAD OF HUMAN RESOURCES USING COMPARISONS TO SALARY SURVEYS FOR SIMILAR POSITIONS AND EXPERIENCE. DURING THE YEAR ENDED MARCH 31, 2011, THE ORGANIZATION HAD AN OUTSIDE COMPENSATION ANALYSIS COMPLETED COVERING EXECUTIVE MANAGEMENT, KEY EMPLOYEES AND HIGHLY COMPENSATED EMPLOYEES. THE BOARD OF DIRECTORS APPROVED COMPENSATION FOR THE CEO AND CFO. THIS PROCESS WAS DOCUMENTED. FORM 990, PART VI, SECTION C, LINE 19 MEMBERS OF THE PUBLIC OR INTERESTED PARTIES MAY REQUEST TO REVIEW OR RECIEVE A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE OR MAIL. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED LOSSES ON INVESTMENTS: -3,959,947. IMPAIRMENT ON OTHER INVESTMENT -4,887,344. K-1 RESEARCH ACTIVITY ALLOCATION 935,966. TOTAL TO FORM 990, PART XI, LINE 5: -7,911,325. ROUNDTRIP LLC 12121 WILSHIRE BLVD STE700 LOS ANGELES CA 90025 RESEARCH & DEVELOPMENT OF LOCATION SYSTEMS DE N/A RELATED -935966 0 0 0.25130 MANN BIOMEDICAL PARK LLC 25134 RYE CANYON LOOP VALENCIA CA 91355 PROPERTY RENTAL CA N/A N/A 0 0 INCUMED LLC 25134 RYE CANYON LOOP 300 VALENCIA CA 91355 HOLDING COMPANY PROVIDING STRATEGIC , OPERATIONAL & CA N/A N/A 0 0 PERQFLO LLC 25134 RYE CANYON LOOP 300 VALENCIA CA 91355 PUMP DEVELOPMENT COMPANY CA N/A N/A 0 0 BIONESS INC 25103 RYE CANYON LOOP VALENCIA CA 91355 DESIGN MANUFACTURE & SALE OF MEDICAL DEVICES DE N/A C 0.03980 NEUROSYSTEC CORPORATION 25134 RYE CANYON LOOP STE 370 VALENCIA CA 91355 PHARMACEUTICAL SOLUTIONS DEVELOPMENT CA N/A C 0 0 0 1 1 0 1 0 1 1 0 0 0 1 1 1 0 0